- Home
- NXPLW vs MWA Comparison
NXPLW vs MWA Comparison
Compare NXPLW & MWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- MWA
- Stock Information
- Founded
- NXPLW N/A
- MWA 1857
- Country
- NXPLW United States
- MWA United States
- Employees
- NXPLW 166
- MWA N/A
- Industry
- NXPLW Telecommunications Equipment
- MWA Metal Fabrications
- Sector
- NXPLW Telecommunications
- MWA Industrials
- Exchange
- NXPLW Nasdaq
- MWA Nasdaq
- Market Cap
- NXPLW N/A
- MWA N/A
- IPO Year
- NXPLW N/A
- MWA 2006
- Fundamental
- Price
- NXPLW $0.18
- MWA $22.87
- Analyst Decision
- NXPLW
- MWA Hold
- Analyst Count
- NXPLW 0
- MWA 5
- Target Price
- NXPLW N/A
- MWA $22.20
- AVG Volume (30 Days)
- NXPLW N/A
- MWA 964.8K
- Earning Date
- NXPLW N/A
- MWA 02-06-2025
- Dividend Yield
- NXPLW N/A
- MWA 1.17%
- EPS Growth
- NXPLW N/A
- MWA 35.28
- EPS
- NXPLW N/A
- MWA 0.74
- Revenue
- NXPLW N/A
- MWA $1,314,700,000.00
- Revenue This Year
- NXPLW N/A
- MWA $4.13
- Revenue Next Year
- NXPLW N/A
- MWA $5.41
- P/E Ratio
- NXPLW N/A
- MWA $30.99
- Revenue Growth
- NXPLW N/A
- MWA 3.06
- 52 Week Low
- NXPLW N/A
- MWA $13.49
- 52 Week High
- NXPLW N/A
- MWA $26.28
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- MWA 48.48
- Support Level
- NXPLW N/A
- MWA $21.35
- Resistance Level
- NXPLW N/A
- MWA $22.80
- Average True Range (ATR)
- NXPLW 0.00
- MWA 0.45
- MACD
- NXPLW 0.00
- MWA 0.11
- Stochastic Oscillator
- NXPLW 0.00
- MWA 84.59
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.